MLH1 and MSH2 expression in pterygia

Cornea

Volumn 26, Issue 4, 2007, Pages 468-472

  Schneider, Barbara G ^a   Sahni, Deshdeepak ^b   Torres, Juan C ^c   Dushku, Nicholas ^d   Reid, Ted W ^e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

^e TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Loss of heterozygosity; Microsatellite instability; Mismatch repair; Pterygium

Indexed keywords

DNA; PROTEIN MLH1; PROTEIN MSH2;

ADULT; AGED; ARTICLE; BASAL CELL; CELL MATURATION; CELL MIGRATION; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; EPITHELIUM CELL; FEMALE; GENE AMPLIFICATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; STAINING;

ADULT; AGED; BASE PAIR MISMATCH; CARRIER PROTEINS; DNA REPAIR; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PTERYGIUM;

EID: 34247634021     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3180316c76     Document Type: Article

References (35)

1. Dushku N, Reid TW. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr Eye Res. 1994;13:473-481.
2. Spandidos DA, Sourvinos G, Kiaris H, et al. Microsatellite instability and loss of heterozygosity in human pterygia. Br J Ophthalmol. 1997;81:493-496.
3. Reisman D, McFadden JW, Lu G. Loss of heterozygosity and p53 expression in pterygium. Cancer Lett. 2004;206:77-83.
4. Detorakis ET, Sourvinos G, Tsamparlakis J, et al. Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations. Br J Ophthalmol. 1998;82:1324-1328.
5. Ionov Y, Peinado MA, Malkhosyan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 1993;363:558-561.
6. Aaltonen LA, Peltomäki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993;260:812-816.
7. Peltomäki P, Lothe RA, Aaltonen LA, et al. Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res. 1993;53:5853-5855.
8. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993;260:816-819.
9. Choy KW, Pang CP, Fan DS, et al. Microsatellite instability and MLH1 promoter methylation in human retinoblastoma. Invest Ophthalmol Vis Sci. 2004;45:3404-3409.
10. Boland CR, Goel A. The silence of the genes: matching mismatch repair defects with tumors. Cancer. 2003;98:2091-2094.
11. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
12. Schneider BG, Bravo JC, Roa JC, et al. Microsatellite instability, prognosis and metastasis in gastric cancers from a low-risk population. Int J Cancer. 2000;89:444-452.
13. Burton MP, Schneider BG, Brown R, et al. Comparison of histologic stains for use in PCR analysis of microdissected, paraffin-embedded tissues. Biotechniques. 1998;24:86-92.
14. Hoang J-M, Cottu PH, Thuille B, et al. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res. 1997;57:300-303.
15. Sieben NL, ter Haar NT, Cornelisse CJ, et al. PCR artifacts in LOH and MSI analysis of microdissected tumor cells. Hum Pathol. 2000;31:1414-1419.
16. Dushku N, Reid TW. p53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr Eye Res. 1997;16:1179-1192.
17. Tan DT, Lim AS, Goh HS, et al. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol. 1997;123:404-405.
18. Chowers I, Pe'er J, Zamir E, et al. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmologica. 2001;108:985-988.
19. Ueda Y, Kanazawa S, Kitaoka T, et al. Immunohistochemical study of p53, p21 and PCNA in pterygium. Acta Histochem. 2001;103:159-165.
20. Weinstein O, Rosenthal G, Zirkin H, et al. Overexpression of p53 tumor suppressor gene in pterygia. Eye. 2002;16:619-621.
21. Tsai Y-Y, Chang K-C, Lin C-L, et al. p53 expresssion in pterygium by immunohistochemical analysis. Cornea. 2005;24:583-586.
22. Schneider BG, John-Aryankalayil M, Rowsey JJ, et al. Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation. Exp Eye Res. 2006;82:91-98.
23. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342-350.
24. Gallagher MJ, Giannoudis A, Herrington CS, et al. Human papillomovirus in pterygium. Br J Ophthalmol. 2001;85:782-784.
25. Dolmetsch AM, Alcocedr CE, Scull JJ, et al. The presence of human papillomavirus in pterygia. Invest Ophthalmol Vis Sci. 1996;37:S43.
26. Piras F, Moore PS, Ugalde J, et al. Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol. 2003;87:864-866.
27. McDonnell JM, McDonnell PJ, Sun YY. Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia. Invest Ophthalmol Vis Sci. 1992;33:184-189.
28. Karcioglu ZA, Issa TM. Human papilloma virus in neoplastic and nonneoplastic conditions of the external eye. Br J Ophthalmol. 1997;81:595-598.
29. Barten M, Ostwald C, Milde-Langosch K, et al. HPV DNA and p53 alterations in oropharyngeal carcinomas. Virchows Arch. 1995;427:153-157.
30. Lam KY, Chan AC, Chan KW, et al. Expression of p53 and its relationship with human papillomavirus in penile carcinomas. Eur J Surg Oncol. 1995;21:613-616.
31. Akasofu M, Oda Y. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18. Virchows Arch. 1995;425:593-602.
32. Dushku N, Hatcher SL, Albert DM, et al. p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch Ophthalmol. 1999;117:1593-1599.
33. Chen KH, Hsu WM, Cheng CC, et al. Lack of human papillomavirus in pterygium of Chinese patients from Taiwan. Br J Ophthalmol. 2003;87:1046-1048.
34. Maskin SL. Regression of limbal epithelial dysplasia with topical interferon. Arch Ophthalmol. 1994;112:1145-1146.
35. Fung-Rong H, Ming-Jet W, Sow-Hsong K. Interferon treatment for corneolimbal squamous dysplasia. Am J Ophthalmol. 1998;125:118-119.